Author

Elin Yulinah

Bandung Institute of Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Acep Riza WijayadikusumahiD· 1 shared Afrillia Nuryanti GarmanaiD· 1 shared Astria Novitasari NidomiD· 1 shared Chairul Anwar NidomiD· 1 shared Darsono Darsono· 1 shared Dhyan K. Ayuningtyas· 1 shared Gembong S. Nugroho· 1 shared I Ketut Adyana· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Acep Riza WijayadikusumahORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Study of the immunogenicity, efficacy and safety of recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in rodent, non-rodent and Maccaca fascicularis using Indonesian Strain Virus

Nur Amalia Limeilati, Reviany V. Nidom, Trilokita Tunjung Sari, Nurvita Putih Kusumarahayu, Siti V. Fransiska, Setyarina Indrasari, Afrillia Nuryanti Garmana, Dhyan K. Ayuningtyas, Gembong S. Nugroho, Darsono Darsono, Maharani Maharani, Acep Riza Wijayadikusumah, Elin Yulinah, I Ketut Adyana, Astria Novitasari Nidom, , Chairul Anwar Nidom

This study evaluates the immunogenicity, efficacy, and safety of a recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in various animal models, showing significant antibody responses and protection against infection.

bioRxiv · Dec 18, 2024 · PreprintImmunology